{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:36:15Z","timestamp":1793050575400,"version":"4.5.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00198-026-08135-x","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:40:16Z","timestamp":1783950016000},"page":"2221-2238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical insights into the association between chronic liver disease and osteoporosis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5800-9014","authenticated-orcid":false,"given":"Huseyin Anil","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-1996","authenticated-orcid":false,"given":"Ahmet","family":"Kahveci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"8135_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/hep.21852","volume":"46","author":"J Collier","year":"2007","unstructured":"Collier J (2007) Bone disorders in chronic liver disease. Hepatology 46:1271\u20131278","journal-title":"Hepatology"},{"key":"8135_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","volume":"45","author":"A Par\u00e9s","year":"2006","unstructured":"Par\u00e9s A, Gua\u00f1abens N (2006) Treatment of bone disorders in liver disease. J Hepatol 45:445\u2013453","journal-title":"J Hepatol"},{"key":"8135_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","volume":"125","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Bernstein CN, Leboff MS (2003) AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125:941\u2013966","journal-title":"Gastroenterology"},{"key":"8135_CR4","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i8.109093","volume":"17","author":"S Pramanik","year":"2025","unstructured":"Pramanik S, Palui R, Ray S (2025) Hepatic osteodystrophy: an underrecognized metabolic bone disease. World J Hepatol 17:10909. https:\/\/doi.org\/10.4254\/wjh.v17.i8.109093","journal-title":"World J Hepatol"},{"key":"8135_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2796.2012.02564.x","volume":"272","author":"M Kawai","year":"2012","unstructured":"Kawai M, de Paula FJ, Rosen CJ (2012) New insights into osteoporosis: the bone-fat connection. J Intern Med 272:317\u2013329. https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02564.x","journal-title":"J Intern Med"},{"key":"8135_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4254\/wjh.v3.i12.300","volume":"3","author":"G L\u00f3pez-Larramona","year":"2011","unstructured":"L\u00f3pez-Larramona G, Lucendo AJ, Gonz\u00e1lez-Castillo S, Tenias JM (2011) Hepatic osteodystrophy: an important matter for consideration in chronic liver disease. World J Hepatol 3:300\u2013307","journal-title":"World J Hepatol"},{"key":"8135_CR7","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.3748\/wjg.v24.i31.3513","volume":"24","author":"CJ Danford","year":"2018","unstructured":"Danford CJ, Trivedi HD, Papamichael K, Tapper EB, Bonder A (2018) Osteoporosis in primary biliary cholangitis. World J Gastroenterol 24:3513\u20133520","journal-title":"World J Gastroenterol"},{"key":"8135_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","volume":"35","author":"KV Menon","year":"2001","unstructured":"Menon KV, Angulo P, Weston S, Dickson ER, Lindor KD (2001) Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 35:316\u2013323","journal-title":"J Hepatol"},{"key":"8135_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4254\/wjh.v10.i10.685","volume":"10","author":"R Shergill","year":"2018","unstructured":"Shergill R, Syed W, Rizvi SA, Singh I (2018) Nutritional support in chronic liver disease and cirrhotics. World J Hepatol 10:685\u2013694","journal-title":"World J Hepatol"},{"key":"8135_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00204-013-1191-5","volume":"88","author":"AK Nussler","year":"2014","unstructured":"Nussler AK, Wildemann B, Freude T et al (2014) Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis. Arch Toxicol 88:997\u20131006","journal-title":"Arch Toxicol"},{"key":"8135_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41574-024-00969-x","volume":"20","author":"S Stegen","year":"2024","unstructured":"Stegen S, Carmeliet G (2024) Metabolic regulation of skeletal cell fate and function. Nat Rev Endocrinol 20:399\u2013413. https:\/\/doi.org\/10.1038\/s41574-024-00969-x","journal-title":"Nat Rev Endocrinol"},{"key":"8135_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1152\/physrev.00043.2020","volume":"102","author":"J Delgado-Calle","year":"2022","unstructured":"Delgado-Calle J, Bellido T (2022) The osteocyte as a signaling cell. Physiol Rev 102:379\u2013410. https:\/\/doi.org\/10.1152\/physrev.00043.2020","journal-title":"Physiol Rev"},{"key":"8135_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-pathmechdis-031521-040919","volume":"18","author":"DJ Veis","year":"2023","unstructured":"Veis DJ, O\u2019Brien CA (2023) Osteoclasts, master sculptors of bone. Annu Rev Pathol 18:257\u2013281. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-040919","journal-title":"Annu Rev Pathol"},{"key":"8135_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrgastro.2009.166","volume":"6","author":"IA Nakchbandi","year":"2009","unstructured":"Nakchbandi IA, van der Merwe SW (2009) Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol 6:660\u2013670","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8135_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11739-018-1874-2","volume":"14","author":"R Nuti","year":"2019","unstructured":"Nuti R, Brandi ML, Checchia G et al (2019) Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med 14:85\u2013102. https:\/\/doi.org\/10.1007\/s11739-018-1874-2","journal-title":"Intern Emerg Med"},{"key":"8135_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393:364\u2013376","journal-title":"Lancet"},{"issue":"Suppl 4","key":"8135_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161435.GL","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Petak SM, Binkley N et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract 22(Suppl 4):1\u201342","journal-title":"Endocr Pract"},{"key":"8135_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00198-008-0701-4","volume":"20","author":"L Valenti","year":"2009","unstructured":"Valenti L, Varenna M, Fracanzani AL et al (2009) Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 20:549\u2013555","journal-title":"Osteoporos Int"},{"key":"8135_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/794862","volume":"2015","author":"N Lu","year":"2015","unstructured":"Lu N, Liu Y, Tang A, Chen L, Miao D, Yuan X (2015) Hepatocyte-specific ablation of PP2A catalytic subunit \u03b1 attenuates liver fibrosis progression via TGF-\u03b21\/Smad signaling. BioMed Res Int 2015:794862","journal-title":"BioMed Res Int"},{"key":"8135_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jhep.2015.09.025","volume":"64","author":"SS Lai","year":"2016","unstructured":"Lai SS, Zhao DD, Cao P et al (2016) PP2Ac\u03b1 positively regulates the termination of liver regeneration in mice through the AKT\/GSK3\u03b2\/Cyclin D1 pathway. J Hepatol 64:352\u2013360","journal-title":"J Hepatol"},{"key":"8135_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.18632\/aging.100725","volume":"7","author":"L Xian","year":"2015","unstructured":"Xian L, Hou S, Huang Z et al (2015) Liver-specific deletion of Ppp2c\u03b1 enhances glucose metabolism and insulin sensitivity. Aging (Albany NY) 7:223\u2013232","journal-title":"Aging (Albany NY)"},{"key":"8135_CR22","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/hep.24605","volume":"54","author":"S Ruiz-Gasp\u00e0","year":"2011","unstructured":"Ruiz-Gasp\u00e0 S, Martinez-Ferrer A, Gua\u00f1abens N et al (2011) Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases. Hepatology 54:2104\u20132113","journal-title":"Hepatology"},{"key":"8135_CR23","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/eci.12355","volume":"44","author":"S Ruiz-Gasp\u00e0","year":"2014","unstructured":"Ruiz-Gasp\u00e0 S, Dubreuil M, Gua\u00f1abens N et al (2014) Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis. Eur J Clin Invest 44:1206\u20131214","journal-title":"Eur J Clin Invest"},{"key":"8135_CR24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/liv.13730","volume":"38","author":"N Gua\u00f1abens","year":"2018","unstructured":"Gua\u00f1abens N, Par\u00e9s A (2018) Osteoporosis in chronic liver disease. Liver Int 38:776\u2013785. https:\/\/doi.org\/10.1111\/liv.13730","journal-title":"Liver Int"},{"key":"8135_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T (2017) Role and mechanism of action of sclerostin in bone. Bone 96:29\u201337","journal-title":"Bone"},{"key":"8135_CR26","first-page":"1356","volume":"85","author":"N Gua\u00f1abens","year":"1990","unstructured":"Gua\u00f1abens N, Par\u00e9s A, Mari\u00f1oso L et al (1990) Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 85:1356\u20131362","journal-title":"Am J Gastroenterol"},{"key":"8135_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1053\/jhep.2002.36357","volume":"36","author":"MM Guichelaar","year":"2002","unstructured":"Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE (2002) Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology 36:895\u2013903","journal-title":"Hepatology"},{"key":"8135_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.0106-9543.2002.01566.x","volume":"22","author":"Z Ackerman","year":"2002","unstructured":"Ackerman Z, Weinreb M, Amir G, Pollak RD (2002) Bone mineral metabolism and histomorphometry in rats with cholestatic liver disease. Liver 22:166\u2013172","journal-title":"Liver"},{"key":"8135_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1359\/jbmr.1998.13.4.731","volume":"13","author":"N Gua\u00f1abens","year":"1998","unstructured":"Gua\u00f1abens N, Par\u00e9s A, Alvarez L et al (1998) Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. J Bone Miner Res 13:731\u2013738","journal-title":"J Bone Miner Res"},{"key":"8135_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jocd.2013.08.017","volume":"16","author":"MS Hamidi","year":"2013","unstructured":"Hamidi MS, Gajic-Veljanoski O, Cheung AM (2013) Vitamin K and bone health. J Clin Densitom 16:409\u2013413","journal-title":"J Clin Densitom"},{"key":"8135_CR31","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/archinte.166.12.1256","volume":"166","author":"S Cockayne","year":"2006","unstructured":"Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ (2006) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166:1256\u20131261","journal-title":"Arch Intern Med"},{"key":"8135_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1615\/CritRevEukarGeneExpr.v11.i1-3.100","volume":"11","author":"JP van Leeuwen","year":"2001","unstructured":"van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA (2001) Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 11:199\u2013226","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"8135_CR33","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116:1202\u20131209","journal-title":"J Clin Invest"},{"key":"8135_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0168-8278(98)80211-0","volume":"28","author":"A Cemborain","year":"1998","unstructured":"Cemborain A, Castilla-Cort\u00e1zar I, Garc\u00eda M et al (1998) Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol 28:122\u2013131","journal-title":"J Hepatol"},{"key":"8135_CR35","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/jbmr.20","volume":"25","author":"S Elis","year":"2010","unstructured":"Elis S, Courtland HW, Wu Y et al (2010) Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1. J Bone Miner Res 25:1257\u20131266","journal-title":"J Bone Miner Res"},{"key":"8135_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.14740\/jocmr2761w","volume":"9","author":"RG de la Garza","year":"2017","unstructured":"de la Garza RG, Morales-Garza LA, Martin-Estal I, Castilla-Cortazar I (2017) Insulin-like growth factor-1 deficiency and cirrhosis establishment. J Clin Med Res 9:233\u2013247","journal-title":"J Clin Med Res"},{"key":"8135_CR37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1210\/jc.2007-1645","volume":"93","author":"IA Nakchbandi","year":"2008","unstructured":"Nakchbandi IA, Lang R, Kinder B, Insogna KL (2008) The role of the receptor activator of nuclear factor-kappaB ligand\/osteoprotegerin cytokine system in primary hyperparathyroidism. J Clin Endocrinol Metab 93:967\u2013973","journal-title":"J Clin Endocrinol Metab"},{"key":"8135_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"LC Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2\u201312","journal-title":"J Bone Miner Res"},{"key":"8135_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jhep.2005.05.034","volume":"43","author":"AR Moschen","year":"2005","unstructured":"Moschen AR, Kaser A, Stadlmann S et al (2005) The RANKL\/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol 43:973\u2013983","journal-title":"J Hepatol"},{"key":"8135_CR40","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.2042-7158.2010.01120.x","volume":"62","author":"M Saito-Yabe","year":"2010","unstructured":"Saito-Yabe M, Kasuya Y, Yoshigae Y et al (2010) PEGylation of osteoprotegerin\/osteoclastogenesis inhibitory factor (OPG\/OCIF) results in decreased uptake into rats and human liver. J Pharm Pharmacol 62:985\u2013994","journal-title":"J Pharm Pharmacol"},{"key":"8135_CR41","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1159\/000465455","volume":"41","author":"Q Wu","year":"2017","unstructured":"Wu Q, Zhou X, Huang D, Ji Y, Kang F (2017) IL-6 enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro. Cell Physiol Biochem 41:1360\u20131369","journal-title":"Cell Physiol Biochem"},{"key":"8135_CR42","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1210\/jc.2001-011814","volume":"87","author":"IA Nakchbandi","year":"2002","unstructured":"Nakchbandi IA, Mitnick MA, Lang R et al (2002) Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 87:4946\u20134951","journal-title":"J Clin Endocrinol Metab"},{"key":"8135_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.17219\/acem\/67561","volume":"27","author":"M Blaschke","year":"2018","unstructured":"Blaschke M, Koepp R, Cortis J et al (2018) IL-6, IL-1\u03b2, and TNF-\u03b1 only in combination influence the osteoporotic phenotype in Crohn\u2019s patients via bone formation and bone resorption. Adv Clin Exp Med 27:45\u201356","journal-title":"Adv Clin Exp Med"},{"key":"8135_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154677","volume":"11","author":"X Li","year":"2016","unstructured":"Li X, Zhou ZY, Zhang YY, Yang HL (2016) IL-6 contributes to the defective osteogenesis of bone marrow stromal cells from the vertebral body of the glucocorticoid-induced osteoporotic mouse. PLoS ONE 11:e0154677","journal-title":"PLoS ONE"},{"key":"8135_CR45","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/art.24781","volume":"60","author":"R Axmann","year":"2009","unstructured":"Axmann R, B\u00f6hm C, Kr\u00f6nke G, Zwerina J, Smolen J, Schett G (2009) Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum 60:2747\u20132756","journal-title":"Arthritis Rheum"},{"key":"8135_CR46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/intimm\/dxq431","volume":"22","author":"YM Lee","year":"2010","unstructured":"Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y (2010) IL-1 plays an important role in the bone metabolism under physiological conditions. Int Immunol 22:805\u2013816","journal-title":"Int Immunol"},{"key":"8135_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/er.2007-0038","volume":"29","author":"J Lorenzo","year":"2008","unstructured":"Lorenzo J, Horowitz M, Choi Y (2008) Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29:403\u2013440","journal-title":"Endocr Rev"},{"key":"8135_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2302\/kjm.54.127","volume":"54","author":"BF Boyce","year":"2005","unstructured":"Boyce BF, Li P, Yao Z et al (2005) TNF-alpha and pathologic bone resorption. Keio J Med 54:127\u2013131","journal-title":"Keio J Med"},{"key":"8135_CR49","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1172\/JCI87430","volume":"126","author":"J Iqbal","year":"2016","unstructured":"Iqbal J, Yuen T, Sun L, Zaidi M (2016) From the gut to the strut: where inflammation reigns, bone abstains. J Clin Invest 126:2045\u20132048","journal-title":"J Clin Invest"},{"key":"8135_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1196\/annals.1346.055","volume":"1068","author":"M Pazianas","year":"2006","unstructured":"Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR (2006) The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn\u2019s disease. Ann N Y Acad Sci 1068:543\u2013556","journal-title":"Ann N Y Acad Sci"},{"key":"8135_CR51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3349\/ymj.2001.42.5.547","volume":"42","author":"MA Karan","year":"2001","unstructured":"Karan MA, Erten N, Tascioglu C et al (2001) Osteodystrophy in posthepatitic cirrhosis. Yonsei Med J 42:547\u2013552","journal-title":"Yonsei Med J"},{"key":"8135_CR52","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00198-003-1434-z","volume":"14","author":"RS Weinstein","year":"2003","unstructured":"Weinstein RS, Parfitt AM, Marcus R, Greenwald M, Crans G, Muchmore DB (2003) Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporos Int 14:814\u2013822","journal-title":"Osteoporos Int"},{"key":"8135_CR53","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1056\/NEJMcp070677","volume":"357","author":"GD Braunstein","year":"2007","unstructured":"Braunstein GD (2007) Clinical practice. Gynecomastia. N Engl J Med 357:1229\u20131237","journal-title":"N Engl J Med"},{"key":"8135_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2796.2004.01342.x","volume":"256","author":"S Ormarsd\u00f3ttir","year":"2004","unstructured":"Ormarsd\u00f3ttir S, Mallmin H, Naess\u00e9n T et al (2004) An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. J Intern Med 256:63\u201369","journal-title":"J Intern Med"},{"key":"8135_CR55","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2265.2012.04347.x","volume":"77","author":"M Grossmann","year":"2012","unstructured":"Grossmann M, Hoermann R, Gani L et al (2012) Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clin Endocrinol 77:323\u2013328","journal-title":"Clin Endocrinol"},{"key":"8135_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1600-0676.1992.tb00560.x","volume":"12","author":"KL S\u00f8e","year":"1992","unstructured":"S\u00f8e KL, S\u00f8e M, Gluud C (1992) Liver pathology associated with the use anabolic-androgenic steroids. Liver Int 12:73\u201379","journal-title":"Liver Int"},{"key":"8135_CR57","first-page":"389","volume":"21","author":"KD Lindor","year":"1995","unstructured":"Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER (1995) Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21:389\u2013392","journal-title":"Hepatology"},{"key":"8135_CR58","first-page":"491","volume":"6","author":"S Nair","year":"2010","unstructured":"Nair S (2010) Vitamin D deficiency and liver disease. Gastroenterol Hepatol 6:491\u2013493","journal-title":"Gastroenterol Hepatol"},{"key":"8135_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3350\/cmh.2020.0189","volume":"27","author":"A Komori","year":"2021","unstructured":"Komori A (2021) Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol 27:58\u201369. https:\/\/doi.org\/10.3350\/cmh.2020.0189","journal-title":"Clin Mol Hepatol"},{"key":"8135_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ecl.2021.03.002","volume":"50","author":"J Homik","year":"2021","unstructured":"Homik J, Suarez-Almazor ME, Shea B et al (2021) Glucocorticoid- and transplantation-induced osteoporosis. Endocrinol Metab Clin North Am 50:251\u2013273. https:\/\/doi.org\/10.1016\/j.ecl.2021.03.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"8135_CR61","doi-asserted-by":"publisher","unstructured":"Calcium and vitamin D for corticosteroid-induced osteoporosis (2000) Cochrane Database Syst Rev 1998:CD000952. https:\/\/doi.org\/10.1002\/14651858.CD000952","DOI":"10.1002\/14651858.CD000952"},{"key":"8135_CR62","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmet.2022.02.006","volume":"34","author":"K Lu","year":"2022","unstructured":"Lu K, Shi TS, Shen SY et al (2022) Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression. Cell Metab 34:441-457.e7","journal-title":"Cell Metab"},{"key":"8135_CR63","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/lt.20874","volume":"12","author":"MM Guichelaar","year":"2006","unstructured":"Guichelaar MM, Kendall R, Malinchoc M, Hay JE (2006) Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 12:1390\u20131402","journal-title":"Liver Transpl"},{"key":"8135_CR64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/gut.49.2.282","volume":"49","author":"J Newton","year":"2001","unstructured":"Newton J, Francis R, Prince M et al (2001) Osteoporosis in primary biliary cirrhosis revisited. Gut 49:282\u2013287","journal-title":"Gut"},{"key":"8135_CR65","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","volume":"138","author":"N Gua\u00f1abens","year":"2010","unstructured":"Gua\u00f1abens N, Cerd\u00e1 D, Monegal A et al (2010) Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology 138:2348\u20132356","journal-title":"Gastroenterology"},{"key":"8135_CR66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","volume":"140","author":"P Angulo","year":"2011","unstructured":"Angulo P, Grandison GA, Fong DG et al (2011) Bone disease in patients with primary sclerosing cholangitis. Gastroenterology 140:180\u2013188","journal-title":"Gastroenterology"},{"key":"8135_CR67","first-page":"1809","volume":"24","author":"L Sinigaglia","year":"1997","unstructured":"Sinigaglia L, Fargion S, Fracanzani AL et al (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24:1809\u20131813","journal-title":"J Rheumatol"},{"key":"8135_CR68","doi-asserted-by":"publisher","first-page":"430","DOI":"10.7326\/0003-4819-110-6-430","volume":"110","author":"T Diamond","year":"1989","unstructured":"Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110:430\u2013436","journal-title":"Ann Intern Med"},{"key":"8135_CR69","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00198-005-1934-0","volume":"16","author":"P Guggenbuhl","year":"2005","unstructured":"Guggenbuhl P, Deugnier Y, Boisdet JF et al (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16:1809\u20131814","journal-title":"Osteoporos Int"},{"key":"8135_CR70","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10545-015-9815-y","volume":"38","author":"KH Weiss","year":"2015","unstructured":"Weiss KH, Van de Moortele M, Gotthardt DN et al (2015) Bone demineralisation in a large cohort of Wilson disease patients. J Inherit Metab Dis 38:949\u2013956","journal-title":"J Inherit Metab Dis"},{"key":"8135_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00198-017-4295-6","volume":"29","author":"J Chenbhanich","year":"2018","unstructured":"Chenbhanich J, Thongprayoon C, Atsawarungruangkit A, Phupitakphol T, Cheungpasitporn W (2018) Osteoporosis and bone mineral density in patients with Wilson\u2019s disease: a systematic review and meta-analysis. Osteoporos Int 29:315\u2013322","journal-title":"Osteoporos Int"},{"key":"8135_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1465-9921-11-173","volume":"11","author":"JM Duckers","year":"2010","unstructured":"Duckers JM, Shale DJ, Stockley RA et al (2010) Cardiovascular and musculoskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency. Respir Res 11:173","journal-title":"Respir Res"},{"key":"8135_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bone.2017.01.006","volume":"97","author":"NR Crabtree","year":"2017","unstructured":"Crabtree NR, Chapman S, H\u00f6gler W et al (2017) Vertebral fractures assessment in children: evaluation of DXA imaging versus conventional spine radiography. Bone 97:168\u2013174. https:\/\/doi.org\/10.1016\/j.bone.2017.01.006","journal-title":"Bone"},{"key":"8135_CR74","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.rmed.2014.05.001","volume":"108","author":"TJ Ringbaek","year":"2014","unstructured":"Ringbaek TJ, Seersholm N, Perch M, Iversen M, Lange P (2014) Prognosis of patients with alpha1-antitrypsine deficiency on long-term oxygen therapy. Respir Med 108:1189\u20131194","journal-title":"Respir Med"},{"key":"8135_CR75","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jbmr.3447","volume":"33","author":"LM Ward","year":"2018","unstructured":"Ward LM, Ma J, Lang B et al (2018) Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study. J Bone Miner Res 33:1435\u20131443. https:\/\/doi.org\/10.1002\/jbmr.3447","journal-title":"J Bone Miner Res"},{"key":"8135_CR76","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00431-022-04455-2","volume":"181","author":"S Ciancia","year":"2022","unstructured":"Ciancia S, van Rijn RR, H\u00f6gler W et al (2022) Osteoporosis in children and adolescents: when to suspect and how to diagnose it. Eur J Pediatr 181:2549\u20132561. https:\/\/doi.org\/10.1007\/s00431-022-04455-2","journal-title":"Eur J Pediatr"},{"key":"8135_CR77","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/M22-0684","volume":"176","author":"C Ayers","year":"2023","unstructured":"Ayers C, Kansagara D, Lazur B et al (2023) Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians. Ann Intern Med 176:182\u2013195. https:\/\/doi.org\/10.7326\/M22-0684","journal-title":"Ann Intern Med"},{"key":"8135_CR78","first-page":"913","volume":"35","author":"S Butin","year":"2017","unstructured":"Butin S, Griffoul I, Espitalier F, Salam\u00e9 E, Mulleman D, Goupille P (2017) High incidence of vertebral osteoporotic fracture within the first year after liver transplantation. Clin Exp Rheumatol 35:913\u2013918","journal-title":"Clin Exp Rheumatol"},{"key":"8135_CR79","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.1840140215","volume":"14","author":"R Eastell","year":"1991","unstructured":"Eastell R, Dickson ER, Hodgson SF et al (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296\u2013300","journal-title":"Hepatology"},{"key":"8135_CR80","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/00365520310000681a","volume":"38","author":"K Bj\u00f8ro","year":"2003","unstructured":"Bj\u00f8ro K, Brandsaeter B, Wiencke K et al (2003) Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Scand J Gastroenterol 38:320\u2013327","journal-title":"Scand J Gastroenterol"},{"key":"8135_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bone.2019.07.006","volume":"127","author":"AD Anastasilakis","year":"2019","unstructured":"Anastasilakis AD, Polyzos SA, Meier C et al (2019) Bone disease following solid organ transplantation: a narrative review and recommendations for management from The European Calcified Tissue Society. Bone 127:401\u2013418","journal-title":"Bone"},{"key":"8135_CR82","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.transproceed.2010.03.096","volume":"42","author":"I Loria","year":"2010","unstructured":"Loria I, Albanese C, Giusto M et al (2010) Bone disorders in patients with chronic liver disease awaiting liver transplantation. Transplant Proc 42:1191\u20131193","journal-title":"Transplant Proc"},{"key":"8135_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191167","volume":"13","author":"PW Schreiber","year":"2018","unstructured":"Schreiber PW, Bischoff-Ferrari HA, Boggian K et al (2018) Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation. PLoS ONE 13:e0191167","journal-title":"PLoS ONE"},{"key":"8135_CR84","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s001980170094","volume":"12","author":"A Monegal","year":"2001","unstructured":"Monegal A, Navasa M, Gua\u00f1abens N et al (2001) Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484\u2013492","journal-title":"Osteoporos Int"},{"key":"8135_CR85","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00042737-199902000-00016","volume":"11","author":"SH Hussaini","year":"1999","unstructured":"Hussaini SH, Oldroyd B, Stewart SP et al (1999) Regional bone mineral density after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 11:157\u2013163","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8135_CR86","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1359\/jbmr.1999.14.2.281","volume":"14","author":"S Vedi","year":"1999","unstructured":"Vedi S, Greer S, Skingle SJ et al (1999) Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 14:281\u2013276","journal-title":"J Bone Miner Res"},{"key":"8135_CR87","doi-asserted-by":"crossref","unstructured":"Mukherjee shadow S, Mukherjee U (2009) A comprehensive review of immunosuppression used for liver transplantation. J Transplant 2009:701464","DOI":"10.1155\/2009\/701464"},{"key":"8135_CR88","volume-title":"Bone disease of organ transplantation","author":"J Compston","year":"2005","unstructured":"Compston J, Shane E (2005) Bone disease of organ transplantation. Elsevier, Amsterdam"},{"key":"8135_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1467825","volume":"16","author":"EG Abate","year":"2025","unstructured":"Abate EG, McKenna A, Yang L, Ball TC, Kearns AE (2025) Five-year evaluation of bone health in liver transplant patients: developing a risk score for predicting bone fragility progression beyond the first year. Front Endocrinol 16:1467825. https:\/\/doi.org\/10.3389\/fendo.2025.1467825","journal-title":"Front Endocrinol"},{"key":"8135_CR90","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2230871","volume":"55","author":"JW Chang","year":"2023","unstructured":"Chang JW, Yang HH, Lin NC et al (2023) Risk factors for fractures following liver transplantation: a population-based cohort study. Ann Med 55:2230871. https:\/\/doi.org\/10.1080\/07853890.2023.2230871","journal-title":"Ann Med"},{"key":"8135_CR91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.abb.2010.05.030","volume":"503","author":"N Gua\u00f1abens","year":"2010","unstructured":"Gua\u00f1abens N, Par\u00e9s A (2010) Liver and bone. Arch Biochem Biophys 503:84\u201394","journal-title":"Arch Biochem Biophys"},{"key":"8135_CR92","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.transproceed.2021.07.049","volume":"53","author":"EF Rodr\u00edguez-Aguilar","year":"2021","unstructured":"Rodr\u00edguez-Aguilar EF, P\u00e9rez-Escobar J, S\u00e1nchez Herrera D et al (2021) Bone disease and liver transplantation: a review. Transplant Proc 53:2346\u20132353. https:\/\/doi.org\/10.1016\/j.transproceed.2021.07.049","journal-title":"Transplant Proc"},{"key":"8135_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK et al (2016) Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 10:1\u201398","journal-title":"Hepatol Int"},{"key":"8135_CR94","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/QAD.0000000000001067","volume":"30","author":"JL Casado","year":"2016","unstructured":"Casado JL, Santiuste C, Vazquez M et al (2016) Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients. AIDS 30:1423\u20131431","journal-title":"AIDS"},{"key":"8135_CR95","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/lt.500040508","volume":"4","author":"HL Reeves","year":"1998","unstructured":"Reeves HL, Francis RM, Manas DM, Hudson M, Day CP (1998) Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transpl Surg 4:404\u2013409","journal-title":"Liver Transpl Surg"},{"key":"8135_CR96","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00198-002-1315-x","volume":"14","author":"P Dodidou","year":"2003","unstructured":"Dodidou P, Bruckner T, Hosch S et al (2003) Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation. Osteoporos Int 14:82\u201389","journal-title":"Osteoporos Int"},{"key":"8135_CR97","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40264-018-0665-z","volume":"41","author":"A Komatsu","year":"2018","unstructured":"Komatsu A, Ikeda A, Kikuchi A, Minami C, Tan M, Matsushita S (2018) Osteoporosis-related fractures in HIV-infected patients receiving long-term tenofovir disoproxil fumarate: an observational cohort study. Drug Saf 41:843\u2013848","journal-title":"Drug Saf"},{"key":"8135_CR98","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/jmv.25433","volume":"91","author":"MT Wei","year":"2019","unstructured":"Wei MT, Le AK, Chang MS et al (2019) Antiviral therapy and the development of osteopenia\/osteoporosis among Asians with chronic hepatitis B. J Med Virol 91:1288\u20131294","journal-title":"J Med Virol"},{"key":"8135_CR99","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/COH.0b013e3281df3410","volume":"2","author":"HC C\u00f4t\u00e9","year":"2007","unstructured":"C\u00f4t\u00e9 HC (2007) Mechanisms of antiretroviral therapy-induced mitochondrial dysfunction. Curr Opin HIV AIDS 2:253\u2013260","journal-title":"Curr Opin HIV AIDS"},{"key":"8135_CR100","first-page":"41","volume":"6","author":"IF Grigsby","year":"2010","unstructured":"Grigsby IF, Pham L, Mansky LM, Gopalakrishnan R, Mansky KC (2010) Tenofovir-associated bone density loss. Ther Clin Risk Manag 6:41\u201347","journal-title":"Ther Clin Risk Manag"},{"key":"8135_CR101","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/COH.0000000000000248","volume":"11","author":"PM Grant","year":"2016","unstructured":"Grant PM, Cotter AG (2016) Tenofovir and bone health. Curr Opin HIV AIDS 11:326\u2013332","journal-title":"Curr Opin HIV AIDS"},{"key":"8135_CR102","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1097\/QAD.0000000000000673","volume":"29","author":"CL Woodward","year":"2015","unstructured":"Woodward CL, Hall AM, Williams IG et al (2015) Tenofovir-associated renal and bone toxicity in HIV-infected patients. AIDS 29:1157\u20131166. https:\/\/doi.org\/10.1097\/QAD.0000000000000673","journal-title":"AIDS"},{"key":"8135_CR103","first-page":"185","volume":"20","author":"RI Gafni","year":"2006","unstructured":"Gafni RI, Hazra R, Reynolds JC et al (2006) Tenofovir disoproxil fumarate decreases bone mineral density without affecting bone turnover in HIV-infected children. AIDS 20:185\u2013194","journal-title":"AIDS"},{"key":"8135_CR104","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/labinvest.2009.14","volume":"89","author":"JJ Kohler","year":"2009","unstructured":"Kohler JJ, Hosseini SH, Hoying-Brandt A et al (2009) Tenofovir renal toxicity targets mitochondria of renal proximal tubules. Lab Invest 89:513\u2013519","journal-title":"Lab Invest"},{"key":"8135_CR105","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jhep.2022.03.033","volume":"77","author":"European Association for the Study of the Liver","year":"2022","unstructured":"European Association for the Study of the Liver (2022) EASL clinical practice guidelines on haemochromatosis. J Hepatol 77:479\u2013502","journal-title":"J Hepatol"},{"key":"8135_CR106","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301184R","volume":"37","author":"F Robin","year":"2023","unstructured":"Robin F, Chappard D, Leroyer P et al (2023) Differences in bone microarchitecture between genetic and secondary iron overload mouse models suggest a role for hepcidin deficiency in iron-related osteoporosis. FASEB J 37:e23245. https:\/\/doi.org\/10.1096\/fj.202301184R","journal-title":"FASEB J"},{"key":"8135_CR107","first-page":"489","volume":"44","author":"P Guggenbuhl","year":"2005","unstructured":"Guggenbuhl P, Deugnier Y, Boisdet JF et al (2005) Bone mineral density in hereditary hemochromatosis: assessment in 60 patients and risk factors for osteoporosis. Rheumatology 44:489\u2013493","journal-title":"Rheumatology"},{"key":"8135_CR108","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.3390\/nu14193911","volume":"14","author":"P D'Amelio","year":"2022","unstructured":"D\u2019Amelio P, Sassi F (2022) Gut-liver-bone axis: the role of iron and hepcidin in bone biomarket regulation. Nutrients 14:3911","journal-title":"Nutrients"},{"key":"8135_CR109","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.3899\/jrheum.100234","volume":"37","author":"P Richette","year":"2010","unstructured":"Richette P, Ottaviani S, Vicaut E, Bardin T (2010) Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol 37:2145\u20132150","journal-title":"J Rheumatol"},{"key":"8135_CR110","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(00)02556-3","volume":"356","author":"M Gu","year":"2000","unstructured":"Gu M, Cooper JM, Butler P et al (2000) Oxidative-phosphorylation defects in liver of patients with Wilson\u2019s disease. Lancet 356:469\u2013474","journal-title":"Lancet"},{"key":"8135_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/cpr.12083","volume":"47","author":"S Li","year":"2014","unstructured":"Li S, Wang M, Chen X, Li SF, Li-Ling J, Xie HQ (2014) Inhibition of osteogenic differentiation of mesenchymal stem cells by copper supplementation. Cell Prolif 47:81\u201390","journal-title":"Cell Prolif"},{"key":"8135_CR112","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/sj.cdd.4401793","volume":"13","author":"YJ Huh","year":"2006","unstructured":"Huh YJ, Kim JM, Kim H et al (2006) Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors. Cell Death Differ 13:1138\u20131146","journal-title":"Cell Death Differ"},{"key":"8135_CR113","doi-asserted-by":"crossref","unstructured":"Ward LM, Weber DR, Munns et al (2020) A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents. J Clin Endocrinol Metab 105:e2088\u2013e2097","DOI":"10.1210\/clinem\/dgz294"},{"key":"8135_CR114","first-page":"1011","volume":"13","author":"L Goldsmith","year":"2021","unstructured":"Goldsmith L, Lovell R (2021) Hepatic osteodystrophy in pediatric chronic liver disease: mechanisms and management. World J Hepatol 13:1011\u20131024","journal-title":"World J Hepatol"},{"key":"8135_CR115","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00467-014-2771-1","volume":"29","author":"IS Tamminen","year":"2014","unstructured":"Tamminen IS, Valta H, Jalanko H et al (2014) Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings. Pediatr Nephrol 29:1431\u20131440","journal-title":"Pediatr Nephrol"},{"key":"8135_CR116","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jocd.2019.07.002","volume":"22","author":"DR Weber","year":"2019","unstructured":"Weber DR, Boyce A, Gordon C et al (2019) The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position. J Clin Densitom 22:567\u2013589. https:\/\/doi.org\/10.1016\/j.jocd.2019.07.002","journal-title":"J Clin Densitom"},{"key":"8135_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10594","volume":"6","author":"M Herath","year":"2022","unstructured":"Herath M, Cohen A, Ebeling PR, Milat F (2022) Dilemmas in the management of osteoporosis in younger adults. JBMR Plus 6:e10594. https:\/\/doi.org\/10.1002\/jbm4.10594","journal-title":"JBMR Plus"},{"key":"8135_CR118","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver (2019) EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol 70:172\u2013193. https:\/\/doi.org\/10.1016\/j.jhep.2018.06.024","journal-title":"J Hepatol"},{"key":"8135_CR119","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S2468-1253(16)30107-8","volume":"1","author":"M Buti","year":"2016","unstructured":"Buti M, Gane E, Seto WK et al (2016) Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol 1:196\u2013206. https:\/\/doi.org\/10.1016\/S2468-1253(16)30107-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8135_CR120","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1128\/AAC.00350-08","volume":"52","author":"KK Van Rompay","year":"2008","unstructured":"Van Rompay KK, Durand-Gasselin L, Brignolo LL et al (2008) Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother 52:3144\u20133160. https:\/\/doi.org\/10.1128\/AAC.00350-08","journal-title":"Antimicrob Agents Chemother"},{"key":"8135_CR121","doi-asserted-by":"publisher","first-page":"950","DOI":"10.14309\/ajg.0000000000003379","volume":"120","author":"AK Singal","year":"2025","unstructured":"Singal AK, Wong RJ, Dasarathy S et al (2025) ACG clinical guideline: malnutrition and nutritional recommendations in liver disease. Am J Gastroenterol 120:950\u2013972. https:\/\/doi.org\/10.14309\/ajg.0000000000003379","journal-title":"Am J Gastroenterol"},{"key":"8135_CR122","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1210\/jc.2012-1027","volume":"97","author":"S Khosla","year":"2012","unstructured":"Khosla S, Bilezikian JP, Dempster DW et al (2012) Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab 97:2272\u20132282. https:\/\/doi.org\/10.1210\/jc.2012-1027","journal-title":"J Clin Endocrinol Metab"},{"key":"8135_CR123","doi-asserted-by":"publisher","unstructured":"Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C (2011) Bisphosphonates for osteoporosis in primary biliary cirrhosis. Cochrane Database Syst Rev CD009144. https:\/\/doi.org\/10.1002\/14651858","DOI":"10.1002\/14651858"},{"key":"8135_CR124","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/andr.12827","volume":"8","author":"V Rochira","year":"2020","unstructured":"Rochira V (2020) Late-onset hypogonadism: bone health. Andrology 8:1539\u20131550. https:\/\/doi.org\/10.1111\/andr.12827","journal-title":"Andrology"},{"issue":"1","key":"8135_CR125","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-019-0087-y","volume":"5","author":"A Salonia","year":"2019","unstructured":"Salonia A, Rastrelli G, Hackett G et al (2019) Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers 5:38. https:\/\/doi.org\/10.1038\/s41572-019-0087-y","journal-title":"Nat Rev Dis Primers"},{"key":"8135_CR126","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ecl.2024.08.005","volume":"53","author":"M Ali","year":"2024","unstructured":"Ali M, Camacho PM (2024) Workup and management of premenopausal osteoporosis. Endocrinol Metab Clin North Am 53:597\u2013606","journal-title":"Endocrinol Metab Clin North Am"},{"key":"8135_CR127","doi-asserted-by":"publisher","DOI":"10.1177\/20420188251347351","volume":"16","author":"S Kurnool","year":"2025","unstructured":"Kurnool S, Shah N, Ekanayake P (2025) Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach. Ther Adv Endocrinol Metab 16:20420188251347351. https:\/\/doi.org\/10.1177\/20420188251347351","journal-title":"Ther Adv Endocrinol Metab"},{"key":"8135_CR128","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1210\/jc.2009-2677","volume":"95","author":"E Canalis","year":"2010","unstructured":"Canalis E (2010) Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 95:1496\u20131504","journal-title":"J Clin Endocrinol Metab"},{"issue":"2 Suppl 1","key":"8135_CR129","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.bone.2005.07.029","volume":"38","author":"PJ Marie","year":"2006","unstructured":"Marie PJ (2006) Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 38(2 Suppl 1):S10-14","journal-title":"Bone"},{"key":"8135_CR130","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2340\/00015555-1014","volume":"91","author":"\u00c1 Kiny\u00f3","year":"2011","unstructured":"Kiny\u00f3 \u00c1, Belso N, Nagy N et al (2011) Strontium ranelate-induced DRESS syndrome with persistent autoimmune hepatitis. Acta Derm Venereol 91:205\u2013206. https:\/\/doi.org\/10.2340\/00015555-1014","journal-title":"Acta Derm Venereol"},{"key":"8135_CR131","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1210\/edrv-14-3-312","volume":"14","author":"M Kleerekoper","year":"1993","unstructured":"Kleerekoper M, Mendlovic DB (1993) Sodium fluoride therapy of postmenopausal osteoporosis. Endocr Rev 14:312\u2013323. https:\/\/doi.org\/10.1210\/edrv-14-3-312","journal-title":"Endocr Rev"},{"key":"8135_CR132","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1016\/j.molcel.2022.07.012","volume":"82","author":"JM Winter","year":"2022","unstructured":"Winter JM, Yadav T, Rutter J (2022) Stressed to death: mitochondrial stress responses connect respiration and apoptosis in cancer. Mol Cell 82:3321\u20133332. https:\/\/doi.org\/10.1016\/j.molcel.2022.07.012","journal-title":"Mol Cell"},{"key":"8135_CR133","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00774-013-0524-z","volume":"32","author":"Y Rhee","year":"2014","unstructured":"Rhee Y, Kim WJ, Han KJ, Lim SK, Kim SH (2014) Effect of liver dysfunction on circulating sclerostin. J Bone Miner Metab 32:545\u2013549","journal-title":"J Bone Miner Metab"},{"key":"8135_CR134","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/apt.18289","volume":"61","author":"L Hartl","year":"2025","unstructured":"Hartl L, Schwarz M, Simbrunner B et al (2025) Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality. Aliment Pharmacol Ther 61:88\u201398. https:\/\/doi.org\/10.1111\/apt.18289","journal-title":"Aliment Pharmacol Ther"},{"key":"8135_CR135","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/jmf.2023.K.0024","volume":"26","author":"KH Leem","year":"2023","unstructured":"Leem KH, Kim S, Lim J, Park HJ, Shin YC, Lee JS (2023) Hydrolyzed collagen tripeptide promotes longitudinal bone growth in childhood rats via increases in insulin-like growth factor-1 and bone morphogenetic proteins. J Med Food 26:809\u2013819. https:\/\/doi.org\/10.1089\/jmf.2023.K.0024","journal-title":"J Med Food"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08135-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08135-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08135-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:03:02Z","timestamp":1793048582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08135-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":135,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8135"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08135-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The investigations conformed to the principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the guardians of the patients for publication of this case report.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}